External quality assessment of anti-tuberculosis drug susceptibility testing for diagnosing extensively drug-resistant Mycobacterium tuberculosis, Academic award, Japanese society for tuberculosis
2018
Incentive award, Japan Veterinary Medical Association
2017
Medal of Honour, National Centre for Communicable Disease, Mongolia, National Centre for Communicable Diseases
May 2011
Highest medal of honor, Ministry of Health, Mongolia
Mar 2004
Drug Susceptibilities and Clinical Manifestations of Mycobacterium tuberculosis in Zambia 2000, Incentive award, Japanese society for tropical medicine
Levofloxacin (LVFX) is a newly developed antibacterial agent derived from fluorinated quinolone. We carried out laboratory and clinical studies to evaluate its usefulness in respiratory infections. Thein vitro antibacterial activity of LVFX...
Clinical evaluation of polymerase chain reaction amplification method for the diagnosis of pulmonary tuberculosis in patients with negative acid-fast bacilli smear
Mitarai S, Oishi K, Fukasawa M, Yamashita H, Nagatake T and Matsumoto K
Tohoku J. Exp. Med. Nagasaki University 177 13-23 Jan 1995 [Refereed]
Japanese Journal of Chemotherapy 43 265-274 Nov 1995 [Refereed]
Balofloxacin (BLFX) is a newly developed antibacterial agent derived from fluorinated quinolone. We carried out laboratory and clinical studies to evaluate its usefulness in respiratory infections. The in vitro antibacterial activity of BLF...
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS
23. Mayanja K H, Oishi K, Mitarai S, Yamashita H, Nalongo K, Watanabe K, Izumi T, Jungala O, Augustine K, Mugeruwa R, Nagatake T, and Matsumoto K
Clin. Infect. Dis. 26 1362-1366 1998 [Refereed]
Comparative study of the Amplicor Mycobacterium and conventional methods for diagnosing of pleuritis caused by mycobacterial infection
Mitarai S, Shishido H, Kurashima A, Tamura A, Nagai H
Int. J. Tuberc. Lung. Dis 40 871-876 2000 [Refereed]
Emergence of new HIV-1 subtype other than subtype C among antenatal women in Lusaka, Zambia
Handema A, Terunuma H, Kasolo F, Kasai H, Sichone M, Mulundu G, Deng X, Ichiyama K, Mitarai S, Honda M, Yamamoto N, and Ito M
AIDS Research and Human Retroviruses 177 759-763 2001 [Refereed]
Potential use of amplicor PCR kit in diagnosing pulmonary tuberculosis from gastric aspirate
Mitarai S, Tanoue S, Sugita C, Sugihara E, Tamura A, Nagano Y, Tsuboi T, Nagayama N, Kurashima A, Nagai H, and Shishido H
J. Microbiol. Method 47 339-344 2001 [Refereed]
Clinical evaluation of Amplicor Mycobacterium detection system for the diagnosis of pulmonary mycobacterial Infection using sputum
Mitarai S, Kurashima A, Tamura A, Nagai H, and Shishido H
Tuberculosis 81 319-325 2001 [Refereed]
Amebiasis in Japanese homosexual men with HIV infection
Mitarai S, Nagai H, Satoh K, Hebisawa A, and Shishido H
Internal Med 40 671-675 2001 [Refereed]
Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples
Kafwabulula M, Ahmed K, Nagatake T, Gotoh J, Mitarai S, Oizumi K, Zumla A
Int. J. Tuberc. Lung. Dis. 6 732-737 2002 [Refereed]
Drug Susceptibilities and Clinical Manifestations of Mycobacterium tuberculosis in Zambia 2000
Mitarai S, Habeenzu C, Lubasi D, Kafwabulula LM, Kasolo FC, Ichiyama K, Terunuma H, Ito M, Shishido H, and Numazaki Y
Jpn. J. Trop. Med. Hyg. 30 23-28 2002 [Refereed]
Comparative study on the use of solid media: Lewenstein-Jensen and Ogawa in the determination of anti-tuberculosis drug susceptibility
Tanoue S, Mitarai S, and Shishido H
Tuberculosis 82 63-675 2002 [Refereed]
[Preventive therapy in middle-aged and elderly persons selected from the population-based screening by mass miniature radiography--methodological aspect and adverse reactions].
Ohmori M, Wada M, Nishii K, Nakazono T, Masuyama H, Yoshiyama T, Inaba K, Itoh K, Uchimura K, Saegusa M, Mitarai S, Kimura M, Shimouchi A
Kekkaku : [Tuberculosis] 77(10) 647-658 Oct 2002 [Refereed]
Specific Detection of Tuberculosis Infection with an Interferon-gamma Based Assay Using New Antigens
Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I
Am J Respir Crit Care Med. 170 59-647 2004 [Refereed]
Evaluation of Modified Ogawa Mycobacterium Culture Method for Higher Sensitivity Employing Concentrated Samples
Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I
American journal of respiratory and critical care medicine 170(1) 59-64 Jul 2004 [Refereed]
[Mycobacterium shinshuense isolated from cutaneous ulcer lesion of right lower extremity in a 37-year-old woman].
Kazumi Y, Ohtomo K, Takahashi M, Mitarai S, Sugawara I, Izumi J, Andoh A, Hasegawa H
Journal of clinical microbiology 43(3) 1473-1474 Mar 2005 [Refereed]
[The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
Mitarai S, Committee for Mycobacterial Examinations,Japanese Society for Tuberculosis.
Takakura S, Tsuchiya S, Fujihara N, Kudo T, Iinuma Y, Mitarai S, Ichiyama S, Yasukawa K, Ishiguro T
Journal of clinical microbiology 43(5) 2489-2491 May 2005 [Refereed]
Mycobacterium branderi isolated from pus of a right pulmonary cavitary lesion.
Sugawara I, Kazumi Y, Otomo K, Ooki K, Mitarai S, Mori K
Japanese journal of infectious diseases 58(3) 187-188 Jun 2005 [Refereed]
Increased risk of intrauterine transmission of HIV-1 associated with granulocyte elastase in endocervical mucus.
Kaseba-Sata C, Kasolo F, Ichiyama K, Mitarai S, Nishiyama A, Kanayama N, Wakasugi N
Journal of acquired immune deficiency syndromes (1999) 41(2) 249-251 Feb 2006 [Refereed]
[BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
Kobayashi I, Abe C, Mitarai S
Kekkaku : [Tuberculosis] 81(2) 57-62 Feb 2006 [Refereed]
[Tuberculosis control in health care facilities for the elderly, from the viewpoint of risk management].
Ohmori M, Wada M, Mitarai S, Yanai H, Ito K, Yamauchi Y, Shishido S
Kekkaku : [Tuberculosis] 81(2) 71-77 Feb 2006 [Refereed]
[Twice-weekly intermittent chemotherapy during the maintenance phase of the short-course treatment for new patients with pulmonary tuberculosis].
Wada M, Mizoguchi K, Okumura M, Mitarai S, Hoshino H, Ohmori M, Uchimura K, Yoshiyama T, Ogata H
Kekkaku : [Tuberculosis] 81(5) 363-369 May 2006 [Refereed]
[External quality assessment of drug susceptibility testing for Mycobacterium tuberculosis].
Mitarai S, Committee for Mycobacterial Examinations., Japanese Society for Tuberculosis.
Kekkaku : [Tuberculosis] 81(8) 501-509 Aug 2006 [Refereed]
[A case of multidrug-resistant pulmonary tuberculosis cured by the regimen including thiacetazone].
Wada M, Mizutani S, Nakajima Y, Ito K, Mitarai S, Hoshino H, Okumura M, Yoshiyama T, Ogata H
Kekkaku : [Tuberculosis] 82(1) 33-37 Jan 2007 [Refereed]
[Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
Mitarai S, Kobayashi I, Abe C, Wada M, Suzuki K, Takashima T, Kawabe Y, Machida K, Tano M, Takigawa S, Kamada A, Shigetoh E, Fujii S, Mori K, Suyama H, Yano S, Kawashiro T, Ogata H
Kekkaku : [Tuberculosis] 82(5) 449-454 May 2007 [Refereed]
[Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan].
Kazumi Y, Itagaki N, Ohmori M, Wada M, Hoshino H, Mitarai S, Sugawara I, Ishikawa N, Mori T
Kekkaku : [Tuberculosis] 82(12) 891-896 Dec 2007 [Refereed]
Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.
Avihingsanon A, Manosuthi W, Kantipong P, Chuchotaworn C, Moolphate S, Sakornjun W, Gorowara M, Yamada N, Yanai H, Mitarai S, Ishikawa N, Cooper DA, Phanuphak P, Burger D, Ruxrungtham K
Antiviral therapy 13(4) 529-536 2008 [Refereed]
[Stability for long-term storage and reproducibility of positivity in the panel test slide prepared with the polyacrylamide-based artificial sputum].
Yamada H, Matsumoto H, Mitarai S, Fujiki A
Kekkaku : [Tuberculosis] 83(2) 65-71 Feb 2008 [Refereed]
Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, Sasaki Y, Horiba M, Mitarai S, Yonemaru M, Ogata H, Ariga H, Kurashima A, Wada A, Takamori M, Yamagishi F, Suzuki K, Mori T, Ishikawa N
The Journal of infection 56(5) 348-353 May 2008 [Refereed]
[Results of repeated QFT-2G checkings at two-year interval and their comparison with TST results introduced into infection control program for staffs working at a hospital with isolation wards for tuberculosis].
Nakajima Y, Ogata H, Yoshiyama T, Mitarai S, Harada N, Higuchi K, Mori T
Kekkaku : [Tuberculosis] 83(6) 445-450 Jun 2008 [Refereed]
Journal of medical microbiology 57(Pt 7) 873-880 Jul 2008 [Refereed]
[Storage and transport of isolated M. tuberculosis at public and private health institutions in Japan].
Ohkado A, Takahashi C, Horiba M, Murase Y, Mitarai S
Kekkaku : [Tuberculosis] 83(8) 591-598 Aug 2008 [Refereed]
[Rapid, simple genotyping method by the variable numbers of tandem repeats (VNTR) for Mycobacterium tuberculosis isolates in Japan--analytical procedure of JATA (12)-VNTR].
Maeda S, Murase Y, Mitarai S, Sugawara I, Kato S
Kekkaku : [Tuberculosis] 83(10) 673-678 Oct 2008 [Refereed]
[The frontline of clinical mycobacteriology].
Kamada A, Mitarai S
Kekkaku : [Tuberculosis] 83(10) 681-698 Oct 2008 [Refereed]
[The current status and future issues on anti-tuberculosis campaign in Japan (5) The status and problems related to molecular epidemiological studies on tuberculosis organisms].
Maeda S, Mitarai S
[Nihon koshu eisei zasshi] Japanese journal of public health 56(1) 48-51 Jan 2009 [Refereed]
Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M, Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
Lancet (London, England) 373(9678) 1861-1873 May 2009 [Refereed]
[Differential diagnosis for high fever of unknown origin; tuberculosis and non-tuberculosis mycobacterial infections].
Mitarai S
Rinsho byori. The Japanese journal of clinical pathology Suppl 143 51-56 May 2009 [Refereed]
Mitarai S, Kato S, Ogata H, Aono A, Chikamatsu K, Mizuno K, Toyota E, Sejimo A, Suzuki K, Yoshida S, Saito T, Moriya A, Fujita A, Sato S, Matsumoto T, Ano H, Suetake T, Kondo Y, Kirikae T, Mori T
Journal of clinical microbiology 50(3) 884-890 Mar 2012 [Refereed]
Matsumoto T, Ogata H, Toyota E, Suzuki K, Saito T, Fujita A, Suetake T, Chikamatsu K, Mizuno K, Mitarai S
Kekkaku : [Tuberculosis] 88(3) 291-296 Mar 2013 [Refereed]
<p>[Background] Multidrug resistance (MDR) involves resistance to both isoniazid and rifampicin, which makes the treatment of tuberculosis very difficult. Extensive drug resistance (XDR) occurs when, in addition to isoniazid and rifampicin resista...
<p>[Objective] To evaluate the use of SPEED-OLIGO® MYCOBACTERIA (Vircell, Spain) in identifying Mycobacterium species. [Method] We examined 15 type or reference strains of mycobacteria (M.tuberculosis H37Rv and 14 non-tube...
Whole genome sequencing analysis of 108 multidrug-/extensively drug-resistant Mycobacterium tuberculosis isolates from one hospital in high TB incidence in Japan
Research on the technical development of prevention, diagnosis, and treatment of childhood tuberculosis and multiple drug-resistant tuberculosis. Research on confidence in the Mycobacterium tuberculosis test, especially drug sensitivy test.
jata.or.jp